127 related articles for article (PubMed ID: 7730681)
1. Left ventricular opacification after intravenous injection of Albunex. The effect of different administration procedures.
Sonne HS; Christensen PD; Muan B; Assentoft J; Haider T; Kristensen BO
Int J Card Imaging; 1995 Mar; 11(1):47-53. PubMed ID: 7730681
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.
Leischik R; Beller KD; Erbel R
Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247
[TBL] [Abstract][Full Text] [Related]
3. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization.
Yvorchuk KJ; Sochowski RA; Chan KL
J Am Soc Echocardiogr; 1996; 9(4):462-9. PubMed ID: 8827629
[TBL] [Abstract][Full Text] [Related]
4. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular opacification by intravenous contrast echocardiography.
Castini D; Gentile F; Ornaghi M; Mangiarotti E; Garbin M; Ravaglia R; Gioventù M; Mantero A; Corno R; Limido A; Morandi F; Fiorentini C; Pezzano A; Repetto S; Haider T; Morris H; Marelli C
G Ital Cardiol; 1999 Jun; 29(6):620-9. PubMed ID: 10396665
[TBL] [Abstract][Full Text] [Related]
7. Increasing the dose and rate of Albunex infusion leads to superior left ventricular contrast effect.
Dolan MS; Dent J; deFilippi C; Christopher T; Wible JH; Labovitz AJ
J Am Soc Echocardiogr; 1998 May; 11(5):426-32. PubMed ID: 9619613
[TBL] [Abstract][Full Text] [Related]
8. Contrast echocardiography in coronary artery diseased patients: effect of systemic and pulmonary artery pressures on left heart opacification after intravenous injection of Albunex.
Geny B; Piquard F; Muan B; Epailly E; Lambrechs M; Thiranos JC; Petit H; Eisenmann B; Haberey P
Coron Artery Dis; 1997 Feb; 8(2):77-81. PubMed ID: 9211046
[TBL] [Abstract][Full Text] [Related]
9. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres.
Sanders WE; Cheirif J; Desir R; Zoghbi WA; Hoyt BD; Schulz PE; Quiñones MA
Am Heart J; 1991 Dec; 122(6):1660-5. PubMed ID: 1957761
[TBL] [Abstract][Full Text] [Related]
10. On the effect of lung filtering and cardiac pressure on the standard properties of ultrasound contrast agent.
Bouakaz A; de Jong N; Cachard C; Jouini K
Ultrasonics; 1998 Feb; 36(1-5):703-8. PubMed ID: 9651600
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.
Geny B; Mettauer B; Muan B; Bischoff P; Epailly E; Piquard F; Eisenmann B; Haberey P
J Am Coll Cardiol; 1993 Oct; 22(4):1193-8. PubMed ID: 8409060
[TBL] [Abstract][Full Text] [Related]
12. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of left ventricular volume by contrast echocardiography].
Iwamori K; Ishikawa K
Nihon Rinsho; 1998 Apr; 56(4):926-9. PubMed ID: 9577610
[TBL] [Abstract][Full Text] [Related]
14. [Improved left ventricular endocardial detection by a first generation contrast agent. Effect of dose].
Vargas F; Hilbert G; Gruson D; Chene G; Journot V; Diebold B; Roudaut R
Arch Mal Coeur Vaiss; 2000 Jan; 93(1):41-7. PubMed ID: 11227717
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of two air-based contrast agents in dogs.
Uchimoto R; Niwa K; Tsuda N; Miyazawa T; Bräutigam M
Eur J Ultrasound; 2000 May; 11(2):127-33. PubMed ID: 10781661
[TBL] [Abstract][Full Text] [Related]
16. Reduced forward output states affect the left ventricular opacification of intravenously administered Albunex.
Gandhok NK; Block R; Ostoic T; Rawal M; Hickle P; Devries S; Feinstein SB
J Am Soc Echocardiogr; 1997; 10(1):25-30. PubMed ID: 9046490
[TBL] [Abstract][Full Text] [Related]
17. The influence of Albunex on the pulmonary circulation in patients with pulmonary hypertension or left heart failure.
Zotz RJ; Genth S; Mitrovic V; Waaler A; Erbel R; Meyer J
Eur Heart J; 1996 Feb; 17(2):302-7. PubMed ID: 8732386
[TBL] [Abstract][Full Text] [Related]
18. Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans.
Ten Cate FJ; Widimsky P; Cornel JH; Waldstein DJ; Serruys PW; Waaler A
Circulation; 1993 Nov; 88(5 Pt 1):2123-7. PubMed ID: 8222106
[TBL] [Abstract][Full Text] [Related]
19. Differing susceptibility of echocardiographic contrast agents to adverse effects of biologic factors: multicenter, videodensitometric comparison of octafluoropropane-filled microspheres with air-filled microspheres for left ventricular opacification.
Hausnerova E; Gottdiener JS; Gould JJ; Pezzullo JC; Callahan JD; Cohen JL; Bruns DE; Kuvelas MT; West HE; Dittrich HC
J Am Soc Echocardiogr; 1999 Nov; 12(11):957-66. PubMed ID: 10552357
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular volume determination using Albunex.
Zotz RJ; Genth S; Waaler A; Erbel R; Meyer J
J Am Soc Echocardiogr; 1996; 9(1):1-8. PubMed ID: 8679229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]